Public Interest Group on Cancer Research: a successful patient-researcher partnership in Newfoundland and Labrador.

Cancer Caregivers Diversity EDI Family members Newfoundland and Labrador Patient partners Patient partnership Patient-oriented research Public engagement

Journal

Research involvement and engagement
ISSN: 2056-7529
Titre abrégé: Res Involv Engagem
Pays: England
ID NLM: 101708164

Informations de publication

Date de publication:
03 Sep 2022
Historique:
received: 09 07 2022
accepted: 09 08 2022
entrez: 3 9 2022
pubmed: 4 9 2022
medline: 4 9 2022
Statut: epublish

Résumé

Partnering with patients and family members affected by cancer is essential for meaningful research, public engagement and outreach, and advocacy activities. Our objective was to create a public interest group through an academic-community partnership focused on cancer research and public engagement. A purposeful recruitment process was implemented to ensure a diverse and inclusive group. The group meets virtually and communicates by email. The group's activities focus on identifying the needs, priorities, and interests of cancer-affected individuals in the province; consultations; and designing research projects and public outreach activities together. Comprehensive meeting minutes are kept and used to distill discussion points. The work of the group is disseminated through a variety of channels. The public interest group includes 12 cancer patient and family member representatives, in addition to researchers. Discussions by the interest group identified key themes related to: (1) equity issues and regional disparity in provincial oncocare; (2) information needs; (3) need for patient empowerment and public understanding; and (4) family member and partner needs and experiences. To date, the group has co-designed a cancer research proposal and a public engagement/outreach activity. The group also provides consultations on cancer-related projects/public engagement activities and members act as patient partners in specific research and public engagement proposals. The group evolves over time, and increasingly advocates on behalf of cancer patients and families. Retention and satisfaction of the public partners with group activities have been high. The group's work and findings are disseminated to the Provincial Cancer Care Program, as well as to public and scientific stakeholders through local media, academic conferences and presentations, and a dedicated website. Public Interest Group on Cancer Research represents a highly successful patient-researcher partnership in oncology. It designs meaningful and patient-oriented studies and outreach activities in cancer. It also elevates and widely supports cancer patient and family voice. Cancer patients and their family members have unique and lived experience with the condition. Therefore, collaborating with them is important in cancer science. We aimed to create such a collaboration in Newfoundland and Labrador, Canada. In 2021, we successfully formed our diverse collaborative group. Currently, our group includes 12 public representatives. We meet online and discuss matters important to members. We also design studies and events together. Our discussions have identified four topics that need further research and policy changes such as information needs and unique needs of caregivers and family members. Our activities expand over time. For example, lately we started to advocate for other cancer patients and families. In conclusion, we formed a successful cancer patient, family member, and researcher collaborative group. Our work informs the public, healthcare systems, and scientists on important cancer related matters.

Sections du résumé

BACKGROUND BACKGROUND
Partnering with patients and family members affected by cancer is essential for meaningful research, public engagement and outreach, and advocacy activities.
OBJECTIVE OBJECTIVE
Our objective was to create a public interest group through an academic-community partnership focused on cancer research and public engagement.
METHODS METHODS
A purposeful recruitment process was implemented to ensure a diverse and inclusive group. The group meets virtually and communicates by email. The group's activities focus on identifying the needs, priorities, and interests of cancer-affected individuals in the province; consultations; and designing research projects and public outreach activities together. Comprehensive meeting minutes are kept and used to distill discussion points. The work of the group is disseminated through a variety of channels.
RESULTS RESULTS
The public interest group includes 12 cancer patient and family member representatives, in addition to researchers. Discussions by the interest group identified key themes related to: (1) equity issues and regional disparity in provincial oncocare; (2) information needs; (3) need for patient empowerment and public understanding; and (4) family member and partner needs and experiences. To date, the group has co-designed a cancer research proposal and a public engagement/outreach activity. The group also provides consultations on cancer-related projects/public engagement activities and members act as patient partners in specific research and public engagement proposals. The group evolves over time, and increasingly advocates on behalf of cancer patients and families. Retention and satisfaction of the public partners with group activities have been high. The group's work and findings are disseminated to the Provincial Cancer Care Program, as well as to public and scientific stakeholders through local media, academic conferences and presentations, and a dedicated website.
CONCLUSION CONCLUSIONS
Public Interest Group on Cancer Research represents a highly successful patient-researcher partnership in oncology. It designs meaningful and patient-oriented studies and outreach activities in cancer. It also elevates and widely supports cancer patient and family voice.
Cancer patients and their family members have unique and lived experience with the condition. Therefore, collaborating with them is important in cancer science. We aimed to create such a collaboration in Newfoundland and Labrador, Canada. In 2021, we successfully formed our diverse collaborative group. Currently, our group includes 12 public representatives. We meet online and discuss matters important to members. We also design studies and events together. Our discussions have identified four topics that need further research and policy changes such as information needs and unique needs of caregivers and family members. Our activities expand over time. For example, lately we started to advocate for other cancer patients and families. In conclusion, we formed a successful cancer patient, family member, and researcher collaborative group. Our work informs the public, healthcare systems, and scientists on important cancer related matters.

Autres résumés

Type: plain-language-summary (eng)
Cancer patients and their family members have unique and lived experience with the condition. Therefore, collaborating with them is important in cancer science. We aimed to create such a collaboration in Newfoundland and Labrador, Canada. In 2021, we successfully formed our diverse collaborative group. Currently, our group includes 12 public representatives. We meet online and discuss matters important to members. We also design studies and events together. Our discussions have identified four topics that need further research and policy changes such as information needs and unique needs of caregivers and family members. Our activities expand over time. For example, lately we started to advocate for other cancer patients and families. In conclusion, we formed a successful cancer patient, family member, and researcher collaborative group. Our work informs the public, healthcare systems, and scientists on important cancer related matters.

Identifiants

pubmed: 36057599
doi: 10.1186/s40900-022-00380-8
pii: 10.1186/s40900-022-00380-8
pmc: PMC9440646
doi:

Types de publication

Journal Article

Langues

eng

Pagination

46

Subventions

Organisme : Office of Public Engagement, Memorial University
ID : Quick Start Fund

Informations de copyright

© 2022. The Author(s).

Références

Am J Bioeth. 2021 Oct;21(10):44-45
pubmed: 34554061
Eur J Hum Genet. 2020 Jul;28(7):925-937
pubmed: 32467599
Mol Genet Genomic Med. 2018 Nov;6(6):1021-1030
pubmed: 30300963
Can Fam Physician. 2015 Apr;61(4):384, 383
pubmed: 25873711
J Patient Exp. 2020 Dec;7(6):898-905
pubmed: 33457517
Circ Arrhythm Electrophysiol. 2016 Mar;9(3):
pubmed: 26966288
Milbank Q. 2016 Mar;94(1):163-214
pubmed: 26994713
J Gen Intern Med. 2016 Jan;31(1):13-21
pubmed: 26160480
Can Fam Physician. 2017 Feb;63(2):e102-e106
pubmed: 28209701

Auteurs

Sevtap Savas (S)

Division of Biomedical Sciences, Faculty of Medicine, Memorial University, 300 Prince Philip Drive, Room 5M324, St. John's, NL, Canada. savas@mun.ca.
Discipline of Oncology, Faculty of Medicine, Memorial University, St. John's, NL, Canada. savas@mun.ca.
Public Interest Group on Cancer Research, St. John's, NL, Canada. savas@mun.ca.

Holly Etchegary (H)

Public Interest Group on Cancer Research, St. John's, NL, Canada.
Division of Community Health and Humanities, Faculty of Medicine, Memorial University, St. John's, NL, Canada.
NLSUPPORT, Faculty of Medicine, Memorial University, St. John's, NL, Canada.

Teri Stuckless (T)

Discipline of Oncology, Faculty of Medicine, Memorial University, St. John's, NL, Canada.
Public Interest Group on Cancer Research, St. John's, NL, Canada.
Provincial Cancer Care Program, Eastern Health, St. John's, NL, Canada.

Cindy Whitten (C)

Public Interest Group on Cancer Research, St. John's, NL, Canada.
Research and Innovation, Eastern Health, St. John's, NL, Canada.

Jason Wiseman (J)

Public Interest Group on Cancer Research, St. John's, NL, Canada.

Derrick Bishop (D)

Public Interest Group on Cancer Research, St. John's, NL, Canada.

John King (J)

Public Interest Group on Cancer Research, St. John's, NL, Canada.

Janine Cutting (J)

Public Interest Group on Cancer Research, St. John's, NL, Canada.

Darrell Peddle (D)

Public Interest Group on Cancer Research, St. John's, NL, Canada.

Classifications MeSH